Scientific and Official Sources PubChem: BPC-157 sequence-related identity, molecular formula and calculated molecular weight United States FDA: 2026 briefing document for BPC-157 free peptide and BPC-157 acetate ClinicalTrials.gov: BPC-157 safety and pharmacokinetics Phase I registry record Sikiric and colleagues: BPC-157, L-arginine and nitric-oxide-system research Lojo and colleagues: experimental use of BPC-157, L-NAME and L-arginine as separate agents McGuire and colleagues: review of BPC-157 evidence and safety uncertainties United States FDA: safety concerns involving certain bulk substances, including BPC-157 MHRA: borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 World Anti-Doping Agency: 2026 Prohibited List
Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures
Science 273 , 252255 (1996)
mTOR: mammalian Target of Rapamycin
Propionibacteria, e.g., Propionibacterium freudenreichii , have been demonstrated as folate-producing bacteria
Five groups of normal female albino mice (4 mice each) received different doses of soluble BV in 0.9% sterile saline, ranging from 0.1 to 50 mg protein/kg BW
